Sun Pharmaceuticals Industries Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524715 |
NSE Symbol : SUNPHARMA |
P/E(TTM) : 157.19 |
ISIN Demat : INE044A01036 |
Div & Yield% : 0.74 |
EPS(TTM) : 11.60 |
Book Value(₹) : 98.75 |
Market Cap(₹Cr) : 437,482.74 |
Face Value(₹) : 1.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 4,409.74 | 5,536.99 | 4,903.66 | 5,019.54 | 4,383.34 | 5,800.85 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 4,409.74 | 5,536.99 | 4,903.66 | 5,019.54 | 4,383.34 | 5,800.85 |
Other Operating Income | 88.33 | 102.15 | 170.09 | 76.67 | 82.73 | 147.37 |
Other Income | 82.74 | 118.88 | 76.80 | 106.54 | 163.54 | 120.30 |
Total Income | 4,580.81 | 5,758.02 | 5,150.55 | 5,202.75 | 4,629.61 | 6,068.52 |
Total Expenditure | 3,737.00 | 3,745.61 | 3,784.56 | 3,709.89 | 3,666.52 | 6,525.36 |
PBIDT | 843.81 | 2,012.41 | 1,365.99 | 1,492.86 | 963.09 | -456.84 |
Interest | 216.08 | 217.59 | 214.92 | 193.63 | 157.94 | 161.45 |
PBDT | 627.73 | 1,794.82 | 1,151.07 | 1,299.23 | 805.15 | -618.29 |
Depreciation | 369.81 | 393.04 | 399.60 | 392.71 | 415.27 | 411.98 |
Tax | 20.10 | 534.18 | 30.16 | 17.89 | 9.24 | -9.45 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Profit After Tax | 237.82 | 867.60 | 721.31 | 888.63 | 380.64 | -1,020.82 |
Extra-ordinary Items | 0.00 | 0.00 | -67.01 | 0.00 | -145.67 | -2,937.79 |
Adjusted Profit After Extra-ordinary item | 237.82 | 867.60 | 788.32 | 888.63 | 526.31 | 1,916.97 |
EPS (Unit Curr.) | 1.00 | 3.60 | 3.00 | 3.70 | 1.60 | -4.30 |
EPS (Adj) (Unit Curr.) | 1.00 | 3.60 | 3.00 | 3.70 | 1.60 | -4.30 |
Calculated EPS (Unit Curr.) | 0.99 | 3.62 | 3.01 | 3.70 | 1.59 | -4.25 |
Calculated EPS (Adj) (Unit Curr.) | 0.99 | 3.62 | 3.01 | 3.70 | 1.59 | -4.25 |
Calculated EPS (Ann.) (Unit Curr.) | 3.96 | 14.46 | 12.03 | 14.81 | 6.35 | -17.02 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.96 | 14.46 | 12.03 | 14.81 | 6.35 | -17.02 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 850.00 | 0.00 | 0.00 | 0.00 |
Equity | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 19.14 | 36.34 | 27.86 | 29.74 | 21.97 | -7.88 |
PBDTM(%) | 14.24 | 32.42 | 23.47 | 25.88 | 18.37 | -10.66 |
PATM(%) | 5.39 | 15.67 | 14.71 | 17.70 | 8.68 | -17.60 |